Market Tracker

04/26 11:28am ET
35.28
BATS BZX Real-Time Price
As of 11:27am ET
 -0.01 / -0.03%
Today’s Change
28.43
Today|||52-Week Range
36.75
+1.67%
Year-to-Date
FDA Nods to AstraZeneca's Tagrisso for First-Line NSCLC (revised)
Apr 23 / Zacks.com - Paid Partner Content
FDA Nods to AstraZeneca's Tagrisso for First-Line NSCLC
Apr 19 / Zacks.com - Paid Partner Content
AstraZeneca and the Revolving Door
Apr 23 / GuruFocus News - Paid Partner Content
Merck's Keytruda Reduces Death Risk in Melanoma Patients
Apr 16 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR
Apr 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close35.29
Today’s open35.47
Day’s range35.24 - 35.47
Volume116,156
Average volume (3 months)3,924,597
Market cap$85.6B
Data as of 11:27am ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-13.30%
Earnings growth (this year)-15.49%
Earnings growth (next 5 years)+8.17%
Revenue growth (last year)-1.03%
P/E ratio29.8
Price/Sales3.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+2.76+1.76%
LLYEli Lilly and Co+1.13+1.39%
ABTAbbott Laboratories+0.30+0.51%
NVONovo Nordisk+0.33+0.70%
Data as of 11:28am ET, 04/26/2018

Financials

Next reporting dateMay 18, 2018
EPS forecast (this quarter)$0.42
Annual revenue (last year)$22.7B
Annual profit (last year)$3.0B
Net profit margin13.36%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts